NextPlat (NXPL) Common Equity (2010 - 2026)
NextPlat's Common Equity came in at $16.49 million for Q2 2026, down 28.4% from $23.01 million a year earlier and down 0.5% from the prior quarter.
Analysis
NextPlat (NXPL) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, NextPlat's Common Equity was $17.42 million, down 35.0% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 98.5% (FY2020 to FY2025).
- Going back by year, Common Equity was $26.8 million in FY2024 (-44.3%), $48.09 million in FY2023 (+86.6%), $25.78 million in FY2022 (+47.0%) and $17.53 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Common Equity since Q2 2021.
- Year-over-year, Common Equity has declined for eight consecutive quarters, with an average decline of 36.7% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q3 2023 (growth of 172.3%), and the weakest in Q1 2025 (a decline of 47.2%).
- Business Quant data shows NXPL's Common Equity at $16.57 million (Q1 2026), $17.42 million (Q4 2025) and $21.55 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | NextPlat | 24.55 Mn | -25.93 Mn | 4.69 Mn | 16.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.49 Mn |
| Mar 31, 2026 | 16.57 Mn |
| Dec 31, 2025 | 17.42 Mn |
| Sep 30, 2025 | 21.55 Mn |
| Jun 30, 2025 | 23.01 Mn |
| Mar 31, 2025 | 24.85 Mn |
| Dec 31, 2024 | 26.80 Mn |
| Sep 30, 2024 | 29.79 Mn |
| Jun 30, 2024 | 36.97 Mn |
| Mar 31, 2024 | 47.09 Mn |
| Dec 31, 2023 | 48.09 Mn |
| Sep 30, 2023 | 49.54 Mn |
| Jun 30, 2023 | 28.42 Mn |
| Mar 31, 2023 | 24.63 Mn |
| Dec 31, 2022 | 25.78 Mn |
| Sep 30, 2022 | 18.19 Mn |
| Jun 30, 2022 | 22.70 Mn |
| Mar 31, 2022 | 23.71 Mn |
| Dec 31, 2021 | 17.53 Mn |
| Sep 30, 2021 | 18.65 Mn |
API Access
NextPlat Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NXPL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NXPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NXPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();